United States · 
Who invested in CorriXR Therapeutics?
CorriXR Therapeutics's investors include Cortado Ventures.
United States · Series A startup
Who invested in CorriXR Therapeutics
Funding summaryUpdated 26 Oct 2026
$1.0Mraised across 1 round since 2025, from 1 source
- Latest round
- Series A, $1.0MAug 2025
- Investors
- 1
The rounds
- Aug 2025
Founders and team
From the SEC filings it signed: 3 on the team.
- Deborah MooradExecutive Officer, Directori
- Eric KmiecExecutive Officer, Directori
- Jon BrilliantExecutive Officeri
On the board, as filediJanice NevinJeffrey CarperStella Vnook
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about CorriXR Therapeutics
How much has CorriXR Therapeutics raised?
CorriXR Therapeutics has raised $1.0M across 1 round since 2025.
When did CorriXR Therapeutics last raise?
CorriXR Therapeutics's most recent round was a Series A of $1.0M in Aug 2025.
What was CorriXR Therapeutics's biggest round?
Its most recent round, $1.0M in Aug 2025, is also its largest on record.
Who backed CorriXR Therapeutics first?
CorriXR Therapeutics's first round on record, in Aug 2025, was backed by Cortado Ventures.
What stage is CorriXR Therapeutics at?
CorriXR Therapeutics's latest named round is a Series A, in Aug 2025.
Where is CorriXR Therapeutics based?
CorriXR Therapeutics is based in the United States.
Companies like CorriXR Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.